1-3 of 3
Thomas Weart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world comparison of treatment outcomes between BCL2i and 2nd generation BTKi therapy in first-line CLL patients

Free
Rushir Choksi, Aliakbar Dadla, Thomas Weart, Brian Mulherin, Taral Patel, Fred Kudrik, Tejvir Singh, Anna Rui, Gino Cioffi, Don Parris, Mike Gart, Janet Donegan, Lisa Morere, Lisa Kunst, Lindsay Aton, Poras Dave, Doug Kanovsky, Jeffrey Scott, Jing-Zhou Hou
Journal: Blood
Blood (2025) 146 (Supplement 1): 4505.
https://doi.org/10.1182/blood-2025-4505
Published: 2025
Journal Articles

Evaluation of real-world outcomes among CLL patients based on sequencing of BTKi and BCL2i therapies

Free
Taral Patel, Rushir Choksi, Tejvir Singh, Aliakbar Dadla, Thomas Weart, Brian Mulherin, Fred Kudrik, Gelareh Rahimi, Gino Cioffi, Don Parris, Anna Rui, Mike Gart, Lisa Kunst, Lindsay Aton, Poras Dave, Doug Kanovsky, Janet Donegan, Lisa Morere, Jeffrey Scott, Jing-Zhou Hou
Journal: Blood
Blood (2025) 146 (Supplement 1): 6286.
https://doi.org/10.1182/blood-2025-6286
Published: 2025
Journal Articles

Initial performance of pirtobrutinib: Real-world outcomes among CLL patients after prior covalent-BTKi and BCL2i use

Free
Rushir Choksi, Aliakbar Dadla, Thomas Weart, Brian Mulherin, Taral Patel, Fred Kudrik, Tejvir Singh, Steven Champaloux, John Li, Anna Rui, Gino Cioffi, Don Parris, Mike Gart, Janet Donegan, Lisa Morere, Lisa Kunst, Lindsay Aton, Jeffrey Scott, Jing-Zhou Hou
Journal: Blood
Blood (2025) 146 (Supplement 1): 6285.
https://doi.org/10.1182/blood-2025-6285
Published: 2025